AKTUALISIERT May 17, 2026
Entdecken Sie French Wachstumsaktien die sich auf der CAC. Nach prognostiziertem Wachstum sortiert, verzeichnen diese stocks im Vergleich zu anderen Unternehmen ein höher als erwartetes Gewinn- oder Umsatzwachstum.
| Unternehmen | Letzter Preis | 7D Rückkehr | 1J Rückkehr | Marktkapitalisierung | Analysten Ziel | Bewertung | Wachstum | Div. Rendite | Industrie | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
EMEIS | €14.74 | 0.6% | 35.4% | €2.4b | €13.49 | PB1.7x | E64.8% | 0% | Healthcare | ||
ALGAE | €0.49 | -7.3% | -17.3% | €44.3m | n/a | PS3.3x | E64.2% | n/a | Materials | ||
ABVX | €95.60 | -8.2% | 1,703.8% | €7.6b | €121.48 | PS1656.5x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
FDE | €36.10 | 1.7% | 30.3% | €191.0m | €55.67 | PE70.7x | E63.6% | n/a | Energy | ||
CRI | €8.46 | -2.0% | -28.3% | €206.1m | €12.28 | PB0.8x | E63.1% | 1.5% | Capital Goods | ||
ALCJ | €2.09 | 9.7% | 9.0% | €113.8m | €4.30 | PS44.3x | E62.8% | n/a | Healthcare | ||
ALMIB | €0.90 | -3.2% | -17.4% | €64.5m | €1.25 | PS89x | E62.7% | n/a | Materials | ||
ALDVI | €0.87 | -7.6% | -51.4% | €12.3m | €3.50 | PS1.7x | E62.7% | n/a | Pharmaceuticals & Biotech | ||
ALLDL | €12.40 | 7.1% | 65.3% | €78.5m | €23.30 | PB0.8x | E61.0% | 3.2% | Retail | ||
UBI | €5.34 | 6.9% | -46.2% | €719.0m | €6.34 | PB0.5x | E60.3% | n/a | Media | ||
LTA | €23.70 | -1.7% | -16.5% | €864.6m | €25.00 | PB0.7x | E60.3% | 0% | Diversified Financials | ||
VLA | €2.47 | -9.9% | -14.6% | €467.9m | €5.23 | PS3x | E59.5% | n/a | Pharmaceuticals & Biotech | ||
KER | €239.50 | 0.4% | 36.4% | €29.4b | €284.52 | PS2x | E59.2% | 1.3% | Consumer Durables | ||
ALTHX | €3.40 | -0.4% | 198.2% | €46.9m | €5.80 | PS57.7x | E57.1% | n/a | Pharmaceuticals & Biotech | ||
GRVO | €19.70 | 1.0% | 9.4% | €28.8m | €21.50 | PE17.9x | E56.8% | 0% | Retail | ||
ADOC | €4.85 | -1.6% | 19.6% | €96.0m | €13.00 | PS24.7x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ALFOR | €0.27 | -3.4% | -45.9% | €31.6m | n/a | PB0.8x | E53.3% | n/a | Capital Goods | ||
ALMDT | €5.19 | 7.9% | 131.7% | €189.0m | €12.13 | PS8.4x | E52.5% | n/a | Healthcare | ||
MEDCL | €26.14 | -3.4% | 66.9% | €983.1m | €34.68 | PS28.9x | E51.7% | n/a | Pharmaceuticals & Biotech | ||
GNFT | €8.42 | -5.0% | 128.2% | €428.2m | €14.00 | PS6.4x | E51.2% | n/a | Pharmaceuticals & Biotech | ||
IPH | €1.95 | 54.4% | 0.5% | €163.3m | €5.35 | PS20.3x | E49.8% | n/a | Pharmaceuticals & Biotech | ||
MF | €87.45 | -0.5% | -4.1% | €3.7b | €106.67 | PB1.1x | E48.0% | 3.4% | Diversified Financials | ||
MLLCB | €2.42 | -6.9% | -29.2% | €10.4m | €2.71 | PE14.2x | E45.9% | n/a | Real Estate Management and Development | ||
VIV | €2.26 | 5.1% | -21.0% | €2.2b | €2.61 | PE124.8x | E45.5% | 1.8% | Media |